ChromaCode, founded by experts from Illumina, Google[x], Luminex, and Caltech, is a molecular diagnostics company with a strong bioinformatics focus. The company's mission is to improve health outcomes by providing access to critical biomarkers for patient management. ChromaCode leverages patented mathematical methods and algorithmic enhancements to enrich signal processing in life science instrumentation. Their flagship product, the High-Definition PCR (HDPCR™) multiplexing platform, offers transformative genomic solutions for physicians.

Notable affiliated individuals include leaders with backgrounds from prestigious institutions like Caltech and industry giants such as Illumina. ChromaCode has attracted significant attention from investors due to its innovative approach to diagnostics. Key achievements include the development and successful implementation of the HDPCR™ platform, which has had a substantial impact on the precision and efficiency of genomic testing. The company continues to make strides in the field of molecular diagnostics, enhancing the capabilities of existing life science technologies and improving patient care.